BioLineRx Ltd (BLRX)

[BooDog]

I'm sure I'm not the only one that was waiting for Nasdaq to issue their non compliance for bid price.

As for the articles, it not just Israeli bio's, I could say the same for Canadian and French as well.

Thier presentations could spark some attention. I'm watching for a more solid bottom.


This is so true, especially on the otc. It's a gamble to see if BLRX ends up there. But they could.....

She said they tend to have small investors as backers. That’s why Israeli-based companies tend to make small progress announcements and treat them as big news. Weinreb said the managers of those Israel biotechs are speaking directly to the small investors who are “eager for exciting short-term events” and are not necessarily “familiar” with the field.


From the 6K...

If the Company does not regain compliance with the minimum bid price requirement by October 22, 2018, Nasdaq may provide written notification to the Company that its securities will be subject to delisting. At that time, the Company may have alternatives to obtain an extension and/or avoid delisting, including an appeal of Nasdaq’s delisting determination to the Nasdaq Listing Qualifications Panel.


The Company intends to monitor the bid price of its ADSs between now and October 22, 2018 and intends to cure the deficiency within the prescribed grace period.

Not really seeing the concern of getting delisted but at least they're not trying to promote themselves. Their silence the whole time under the $ signaled to me that they may have wanted the weakness to bring them into this situation. Nah, that never happens. Unless they thought patent news would do something.

Thanks for sharing Amature.

Message in reply to:

Not sure if effect of this but could be an effect. There are no near term catalyst - everything is long term
—-


Here is and interesting article that I came across in terms Israeli company investments - these were in response to Adam F’s tweet. Seems very relevant and be used as caution by all

http://www.globes.co.il/en/article-israeli-biotechs-the-horrible-truth-1001219626


https://www.biospace.com/article/unique-why-investors-should-avoid-israeli-biotechs-like-the-plague/